All filters
Slidesets
Clinical progress of the entry inhibitor Myrcludex B | Stephan Urban
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Clinical update on reducing HBV virus and antigen production using RNAi | Bruce Given
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Targeting HBV Core Protein to Clear Infection and Achieve Higher Cure Rates | Richard Colonno
Presented at:
International Workshop on HBV Cure 2018
Slidesets
What is the cure rate with current therapies? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Stopping Nucleos(t)ide Analogues: When is it beneficial, when is it dangerous? | Thomas Berg, MD
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Will HBsAg depletion restore HBV specific immunity? | Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2018
Slidesets
What are the pros and cons of HBsAg loss as the endpoint for treatment? | Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Antiviral effect of the RIG-I agonist, Inarigavir | Nezam Afdahl
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Rationale for modulating innate immunity: TLR, RIG- and others | Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Innate activation with Inactivated parapox viruses for HBV therapy - AIC649 | Daniela Paulsen
Presented at:
International Workshop on HBV Cure 2018
Slidesets
Update on changes in Hepatitis B and C in CEE countries- Miłosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Epidemiology of HIV Infection and Treatment in Europe- Teymur Noori, MSc
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Country models: what has and what hasn’t worked- Nikoloz Chkhartishvili, MD, MS, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Country models: what has and what hasn’t worked- Zahedul Islam, MBA
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Hepatitis Delta: what are the new developments, what are the challenges?- Cihan Yurdaydin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Treatment-experienced patients in Central and Eastern Europe – What needs to be done?- Viktor Aster, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
HIV & women’s health: do we have any game changers here?- Mariana Mărdărescu, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Clinical Case Discussion: Switching HIV Therapy- Pavel Khaykin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018
Slidesets
Clinical considerations in switching antiretroviral therapy- David Jilich, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2018